Urology News and Research

Latest Urology News and Research

U.S. News ranks UC San Diego Health System among America's Best Hospitals for 2011-2012

UC San Diego Health System ranks #1 among San Diego's adult hospitals and among "America's Best Hospitals" according to U.S. News & World Report's "2011 - 2012 Best Hospitals" issue online at www.usnews.com/besthospitals and available on newsstands August 30.

21 Jul 2011

FDA panel votes against novel diabetes drug citing adverse effects

An advisory panel for the US Food and Drugs Administration voted 9-6 that the FDA should not yet approve dapagliflozin, a new type of diabetes drug that makes the body dump sugar and lose weight. Signals of possible liver damage and of breast and bladder cancer worried the experts.

20 Jul 2011

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

Ronald Reagan UCLA Medical Center ranks among the top five American hospitals, according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors.

20 Jul 2011

U.S. News ranks NewYork-Presbyterian as sixth best hospital in the nation

NewYork-Presbyterian Hospital ranks #1 in New York and among the top six in the U.S. out of the nearly 5,000 hospitals evaluated by U.S. News Media & World Report for their 2011-12 Best Hospitals rankings.

20 Jul 2011

U.S. News recognizes U of U as No. 1 health care system in Salt Lake City metro area

University of Utah Health Care is the No. 1 health care system in the Salt Lake City metro area, according U.S. News & World Report's 2011-2012 Best Hospitals rankings.

20 Jul 2011

U.S. News & World Report ranks UT Southwestern as best hospital in Dallas-Fort Worth region

For the second year in a row, UT Southwestern Medical Center is the top-ranked hospital in the Dallas-Fort Worth region, according to U.S. News & World Report's annual ranking of the nation's best hospitals.

19 Jul 2011

Aeterna's AEZS-108 final Phase 2 results in endometrial cancer to be presented at ESGO 2011

Aeterna Zentaris Inc. today announced that final Phase 2 results in endometrial cancer on its anticancer compound, AEZS-108, will be presented during a poster session at the upcoming 17th International Meeting of the European Society of Gynaecological Oncology, to be held September 11-14, 2011, at the Milan Convention Center in Milan, Italy.

19 Jul 2011

InterStim Therapy now available for treatment of chronic bowel incontinence

A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function.

19 Jul 2011

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Short-term hormone therapy given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.

14 Jul 2011

Maintaining general health may help reduce risk for dementia

Improving and maintaining health factors not traditionally associated with dementia, such as denture fit, vision and hearing, may lower a person's risk for developing dementia, according to a new study published in the July 13, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jul 2011

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients to greater risk than other surgical options.

14 Jul 2011

Bladder cancer patients rarely receive recommended care: Study

According to a study released this week by UCLA's Jonsson Comprehensive Cancer Center, the overwhelming majority of patients with high-grade non-muscle invasive bladder cancer do not receive the recommended treatment and surveillance, leaving them at higher risk for bladder cancer recurrence, progression, and death.

13 Jul 2011

Sequana Medical's ALFApump System for liver cirrhosis receives CE Mark approval

Sequana Medical announced today that it has received CE Mark approval for the commercial sale of its ALFApump System.

13 Jul 2011

Bladder cancer patients missing out on treatment and followups: Study

A new study released this Monday by UCLA's Jonsson Comprehensive Cancer Center shows a large majority of patients with high-grade non-muscle invasive bladder cancer do not receive the recommended treatment and surveillance, leaving them at higher risk for bladder cancer recurrence, progression, and death.

13 Jul 2011

Men more likely to succumb to cancer

According to a new analysis of 36 different types of tumors and blood cancers that affect both sexes, men are more likely than women to get and die of cancer. The report shows that leukemia and cancers of the colon and rectum, pancreas, and liver killed about one and a half to two times as many men as women in the U.S. over a 30-year period. Lung cancer killed nearly two and a half times as many men during that time. According to the American Cancer Society men have about a 1 in 2 chance of developing cancer at some point in their lives, compared with women, who have a 1 in 3 chance.

13 Jul 2011

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.

11 Jul 2011

Patients with high-grade noninvasive bladder cancer do not receive recommended care

A new study has found that almost all patients with high-grade noninvasive bladder cancer do not receive complete care as recommended by current guidelines.

11 Jul 2011

Scientists discover seven new gene variants that increase risk of prostate cancer

Cancer Research UK-funded scientists have taken a further step to identifying men at a greater risk of prostate cancer with the discovery of seven new variants in the human genome that increase the chances of developing the disease.

11 Jul 2011

Shire files lawsuit against Watson over generic Vyvanse

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.

8 Jul 2011

U.S. District Court rules in favor of Watson over Mucinex patent suit

Watson Pharmaceuticals, Inc. today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex(R), Mucinex(R) D, and Mucinex(R) DM Extended-Release products do not infringe U.S. Patent No. 6,372,252.

8 Jul 2011

Urology News and Research

Latest Urology News and Research

U.S. News ranks UC San Diego Health System among America's Best Hospitals for 2011-2012

FDA panel votes against novel diabetes drug citing adverse effects

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

U.S. News ranks NewYork-Presbyterian as sixth best hospital in the nation

U.S. News recognizes U of U as No. 1 health care system in Salt Lake City metro area

U.S. News & World Report ranks UT Southwestern as best hospital in Dallas-Fort Worth region

Aeterna's AEZS-108 final Phase 2 results in endometrial cancer to be presented at ESGO 2011

InterStim Therapy now available for treatment of chronic bowel incontinence

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Maintaining general health may help reduce risk for dementia

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

Bladder cancer patients rarely receive recommended care: Study

Sequana Medical's ALFApump System for liver cirrhosis receives CE Mark approval

Bladder cancer patients missing out on treatment and followups: Study

Men more likely to succumb to cancer

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Patients with high-grade noninvasive bladder cancer do not receive recommended care

Scientists discover seven new gene variants that increase risk of prostate cancer

Shire files lawsuit against Watson over generic Vyvanse

U.S. District Court rules in favor of Watson over Mucinex patent suit

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in